Akt Deficiency Attenuates Muscle Size and Function but Not the Response to ActRIIB Inhibition
Marcus D. Goncalves, Emidio E. Pistilli, Anthony Balduzzi et al. · 2010
Read Akt Deficiency Attenuates Muscle Size and Function but Not the Response to ActRIIB Inhibition by Marcus D. Goncalves, Emidio E. Pistilli, Anthony Balduzzi et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012707.txt.
Description
Goncalves, Pistilli, Balduzzi and co-authors asked whether a growth signal called Akt is needed for a muscle-building drug to work. Akt drives normal muscle growth as animals develop. Blocking a muscle brake called ActRIIB makes muscles bigger and stronger, a route eyed for wasting diseases.
Their 2010 mouse study found that lacking Akt leaves muscles smaller and weaker, yet the ActRIIB blocker still worked. That split means the drug route does not depend on Akt, good news for patients whose Akt signalling is low. Separate paths to growth give doctors more options.
Catalog record
| CREATOR | Marcus D. Goncalves, Emidio E. Pistilli, Anthony Balduzzi et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012707